Log In Sign Up Premium
#1 AI Stock to Buy
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Economy
    • Industries
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Insider Trading Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Transcripts
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Investor Letters
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing · 30-day money back guarantee

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing

Unlock Now — $9.99
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Insider Monkey Blog

Dianthus (DNTH) Piles Up Clinical Wins While Its Losses Widen

On August 4, Dianthus Therapeutics (NASDAQ:DNTH) reported second-quarter 2026 results alongside a stack of pipeline updates that touched nearly every program the company runs.

Keep Reading →

September 5 - Hedge Funds, News

SoundHound AI Closed Its LivePerson Deal. Does the Acquisition Fix SOUN’s Scale Problem or Import LPSN’s Weaknesses?

LivePerson shareholders approved SoundHound AI's acquisition on September 2, and the companies completed the transaction on September 4.

Keep Reading →

September 5 - News, Stock Analysis

Chagee’s (CHA) Overseas Boom Masks A Bruising Home Market Fight

On August 28, Chagee Holdings Limited (NASDAQ:CHA) reported second-quarter results that read like two different companies stitched together.

Keep Reading →

September 5 - Hedge Funds, News

Jim Cramer Breaks Down P/E Multiples Explaining Why NVIDIA (NVDA) Looks Cheaper Than ServiceNow

During the September 2 episode of Mad Money, Jim Cramer broke down how nominal stock prices can misrepresent reality, as he offered a direct comparison between NVIDIA Corporation...

Keep Reading →

September 5 - News

Hafnia (HAFN) Payouts Surge as Q2 Profit Hits Multi-Year High

On August 28, Hafnia Limited (NYSE:HAFN) reported second-quarter net profit of $277.8 million, its strongest quarterly result since the third quarter of 2022.

Keep Reading →

September 5 - Hedge Funds, News

Jim Cramer Explains Why SanDisk (SNDK) Makes MongoDB (MDB) Look Expensive

When looking at stock market tickers, it is easy to fall into the trap of judging a company by its absolute dollar price rather than what is actually being paid for its earnings...

Keep Reading →

September 5 - News

Jim Cramer Says “Own It, Don’t Trade It” as CVS Health Gains Momentum

A caller on the September 2 episode of Mad Money noted that CVS Health Corporation (NYSE:CVS) is up 21% this year, sports a 3% dividend, and trades at a 28 valuation compared ...

Keep Reading →

September 5 - News

Jim Cramer on PG&E (PCG): Wildfire Liability Puts Growth Plans Under Pressure

On September 2, while discussing how California lawmakers failed to advance wildfire-liability reform, Mad Money host Jim Cramer mentioned PG&E Corporation (NYSE:PCG) and said...

Keep Reading →

September 5 - News

AST SpaceMobile Director Bought $619,000 as Short Interest Reached 57.5 Million Shares. Is the Risk-Reward Turning?

AST SpaceMobile director Adriana Cisneros bought 10,822 shares through three related accounts on August 31.

Keep Reading →

September 5 - News, Stock Analysis

Monolithic Power Revenue Jumped 48%. Can AI Power Chips Keep the Momentum Going?

On July 30, Monolithic Power Systems reported second-quarter revenue of $980.6 million, up 47.6% from a year earlier and 21.9% sequentially.

Keep Reading →

September 5 - News, Stock Analysis

WhiteFiber’s Cloud and Colocation Revenue Grew With 6 Million Shares Sold Short. Is This AI Data-Center Bet a Squeeze or a Trap?

WhiteFiber's August 12 filing showed that second-quarter colocation and cloud-services revenue both increased, while 6.04 million shares were sold short at the August 14 settlement...

Keep Reading →

September 5 - News, Stock Analysis

RingCentral Says Paid-AI Customers Now Represent 13% of ARR as Revenue Grew 6%. Has the Market Already Priced It In?

On July 23, RingCentral said customers using at least one paid native AI product represented about 13% of annual recurring revenue, and that measure had doubled year over year...

Keep Reading →

September 5 - News, Stock Analysis

Robo.ai Says Three Months of Revenue Topped $180 Million. Why Does the Balance Sheet Still Look Fragile?

Robo.ai said preliminary revenue exceeded $180 million from June through August, primarily from QC Capital, which it acquired on June 15.

Keep Reading →

September 5 - News, Stock Analysis

How A Closed Strait Turned Into A Cash Machine For BW LPG (BWLP)

On August 28, BW LPG (NYSE:BWLP) reported second-quarter results that captured just how strange the global LPG shipping market has become.

Keep Reading →

September 5 - Hedge Funds, News

A Judge Spared Alphabet From an Ad-Tech Breakup but Ordered Changes. Does That Protect Its AI War Chest?

A federal judge on September 2 declined to force Google to sell major pieces of its advertising technology business, choosing conduct remedies instead.

Keep Reading →

September 5 - News, Stock Analysis

Lam Research Legal Chief Sold $1.5 Million as AI Chip Demand Booms. Is the Signal Bearish?

Lam Research chief legal officer Ava Harter sold 5,000 shares at $302.46 on August 31, generating about $1.51 million and leaving her with 42,462 shares.

Keep Reading →

September 5 - News, Stock Analysis

bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right?

bioAffinity Technologies jumped 47.95% on September 2, one day after announcing that it was advancing the potential use of CyPath Lung for post-treatment surveillance of lung-...

Keep Reading →

September 5 - News, Stock Analysis

Sprinklr’s Revenue Grew Just 1% and the Stock Fell 9%. Can AI Innovation Break the Slump?

Sprinklr shares fell 8.55% on September 2 after the company reported fiscal second-quarter 2027 results.

Keep Reading →

September 5 - News, Stock Analysis

Pagaya Posted a Record $45 Million Profit. Is AI Lending Finally Working?

On July 30, Pagaya Technologies reported a record $45 million of GAAP net income attributable to shareholders in the second quarter, giving investors a concrete profitability ...

Keep Reading →

September 5 - News, Stock Analysis

Fluence Has a $6.4 Billion Backlog but Pushed $400 Million of Deliveries Out. Is the AI-Power Story Breaking?

In its August 5 results, Fluence Energy ended the fiscal third quarter with a $6.4 billion backlog, yet about $400 million of project deliveries moved into fiscal 2027.

Keep Reading →

September 5 - News, Stock Analysis

Retail Investors Are Chasing Anthropic Before an IPO. Does Destiny Tech100 Offer Exposure or a Premium Trap?

A September 2 WallStreetBets thread asked how retail investors could gain Anthropic exposure before an initial public offering and listed Destiny Tech100 among several proxy routes...

Keep Reading →

September 5 - News, Stock Analysis

Palantir Won a $127 Million Army Production Order and Still Fell 6%. Is the Valuation Finally Catching Up?

The U.S. Army moved its Tactical Intelligence Targeting Access Node, or TITAN, into production on September 1.

Keep Reading →

September 5 - News, Stock Analysis

Western Digital Director Sold $2.5 Million After a Fourfold-Plus Run. Is AI Storage Momentum Peaking?

Western Digital director Stephanie Streeter's family trust sold 5,600 shares across August 31 and September 1 for $2,519,280.

Keep Reading →

September 5 - News, Stock Analysis

Satya Nadella Sold $43 Million of Microsoft Under a Trading Plan. Is the Insider Signal Really Bearish?

Microsoft CEO Satya Nadella sold 86,525 shares on September 1 for approximately $43.39 million.

Keep Reading →

September 5 - News, Stock Analysis

Vistra’s CEO Bought $1.17 Million of Stock After the Selloff. Is AI Power Demand Mispriced?

Vistra President and CEO James Burke bought 8,665 shares in three open-market purchases on August 24, August 31, and September 1, spending $1.17 million.

Keep Reading →

September 5 - News, Stock Analysis

SanDisk (SNDK) Soars on S&P 100 Inclusion; Hedge Fund Ownership More-Than-Doubles

SanDisk Corp.

Keep Reading →

September 4 - Market Movers, News

Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?

GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.

Keep Reading →

September 4 - Hedge Funds, News

Lilly Launches Foundayo in the UK as NICE Review Continues

Eli Lilly and Company (NYSE:LLY) has launched Foundayo in the United Kingdom, making Britain the first European country where the company’s oral treatment for weight management...

Keep Reading →

September 4 - Hedge Funds, News

Could New Long-Term Data Support Capricor’s Duchenne Therapy?

Capricor Therapeutics, Inc. (NASDAQ:CAPR) has gained another opportunity to make the case for deramiocel, its experimental cell therapy for Duchenne muscular dystrophy.

Keep Reading →

September 4 - Hedge Funds, News

Could Roche and Lilly’s Blood Test Make Alzheimer’s Assessment More Accessible?

Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or difficult to access.

Keep Reading →

September 4 - Hedge Funds, News

Regenxbio’s Gene Therapy Faces Another FDA Setback in Hunter Syndrome

Regenxbio Inc. (NASDAQ:RGNX) suffered another setback in its effort to bring RGX-121 to patients with Hunter syndrome.

Keep Reading →

September 4 - Hedge Funds, News

Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection

Guardant Health, Inc.

Keep Reading →

September 4 - Hedge Funds, News

Alibaba’s Wan3.0 Expands Its AI Ambitions, Could Shareholders Be Paying the Bill?

Alibaba Group Holding Limited (NYSE:BABA) has introduced Wan3.0, its latest artificial-intelligence video-generation model, one day after announcing a HK$80 billion ($10.2 billion...

Keep Reading →

September 4 - Hedge Funds, News

Five Below (FIVE) Reported Sales Growth and Authorized a $600M Repurchase Program. Can Recovery Fund Expansion and Capital Returns?

Five Below, Inc. (NASDAQ:FIVE) reported fiscal second-quarter net sales of $1.26 billion, up 22.9% from $1.03 billion one year earlier.

Keep Reading →

September 4 - Hedge Funds, News

Guidewire (GWRE) Grew Fiscal 2026 ARR 19%. Can Cloud Economics Offset Slower Near-Term Growth?

Guidewire Software, Inc. (NYSE:GWRE) reported fiscal fourth-quarter revenue of $411.1 million, up 15%.

Keep Reading →

September 4 - Hedge Funds, News

DocuSign (DOCU) Raised IAM’s Share of ARR to 15%. Can Platform Mix Lift Total ARR Growth Beyond Single Digits?

DocuSign, Inc. (NASDAQ:DOCU) reported fiscal second-quarter 2027 revenue of $875.7 million, up 9% year over year.

Keep Reading →

September 4 - Hedge Funds, News

UiPath (PATH) Grew ARR 12% as Net Retention Rate Reached 109%. Can Agentic Automation Reaccelerate Expansion?

UiPath, Inc.

Keep Reading →

September 4 - Hedge Funds, News

Victoria’s Secret (VSXY) Delivered 9% Comparable-Sales Growth. Can Regular-Price Momentum Survive Higher Marketing Spend?

Victoria's Secret & Co. (NYSE:VSXY) reported fiscal second-quarter net sales of $1.611 billion, up 10%, while comparable sales increased 9%.

Keep Reading →

September 4 - Hedge Funds, News

Aehr Test Systems (AEHR) Climbs 13%; Hedge Fund Holdings Rocket by Eightfold

Aehr Test Systems (NASDAQ:AEHR) saw its share price climb by 13.10 percent on Friday as investors began positioning their portfolios ahead of business updates next week.

Keep Reading →

September 4 - Market Movers, News

Asana (ASAN) Reached a 10% Non-GAAP Operating Margin. Can Agentic Products Restore Expansion?

Asana, Inc.

Keep Reading →

September 4 - Hedge Funds, News

Toro Co (TTC) Grew Third-Quarter Sales 8.4%. Can Residential Gains Offset Professional Margin Compression?

The Toro Company (NYSE:TTC) reported fiscal third-quarter 2026 net sales of $1.226 billion, up 8.4% year over year.

Keep Reading →

September 4 - Hedge Funds, News

Ambarella (AMBA) Grew 2Q Revenue 13.2% and Signed 7-Year Channel Agreements. Can Edge-AI Scale Reverse Margin Compression?

Ambarella, Inc. (NASDAQ:AMBA) reported fiscal second-quarter 2027 revenue of $108.1 million, up 13.2% from $95.5 million a year earlier.

Keep Reading →

September 4 - Hedge Funds, News

Jim Cramer Bullish on MP Materials (MP) But Warns Investors Not to Expect Quick Results

A caller inquired about starting a position in MP Materials Corp.

Keep Reading →

September 4 - News

Concrete Pumping (BBCP) Raised Outlook and Initiated a Dividend After Revenue Growth. Can Infrastructure Demand Fund Returns and Deleveraging?

Concrete Pumping Holdings, Inc. (NASDAQ:BBCP) reported fiscal third-quarter revenue of $116.8 million, up 12.6%, as U.S.

Keep Reading →

September 4 - Hedge Funds, News

ChronoScale Says It Plans a 50 MW Microsoft AI Deployment. Can CHRN Fund the Build Without Diluting Shareholders?

ChronoScale said on August 27 that it plans with Microsoft to deploy 50 megawatts of AI infrastructure in North America using NVIDIA GB300 NVL72 systems and liquid cooling.

Keep Reading →

September 4 - News, Stock Analysis

AWS Plans 2 Million More NVIDIA GPUs. Is This Better News for AMZN’s Cloud Growth or NVDA’s Backlog?

AWS and NVIDIA said on August 26 that Amazon's cloud plans to deploy two million additional Blackwell Ultra, Rubin, and Rubin Ultra GPUs during 2027 and 2028.

Keep Reading →

September 4 - News, Stock Analysis

Entergy Says Google’s Arkansas Solar Payments Could Total $2.1 Billion. Is Power Becoming Alphabet’s New Bottleneck?

Newly reported records put dollar figures on power infrastructure for Google's West Memphis data center, but Entergy says the first $716 million headline understated the full ...

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Discussed The Big Excitement At Gap Inc. (NYSE:GAP)

Apparel retailer Gap Inc. (NYSE:GAP) reported its second quarterearnings on August 27th.

Keep Reading →

September 4 - News

Marvell Raised Its Outlook but Fell as Google Chip Revenue Stayed Distant. Has the AI Payoff Been Priced In? (Ready for review)

Marvell raised its annual forecasts on August 27, yet its shares fell as investors focused on the timing of revenue from a custom AI-chip relationship with Google.

Keep Reading →

September 4 - News, Stock Analysis

Jim Cramer Thinks This Struggling Stock Could See A “Big Earnings Acceleration”

Human resources and financial software provider Workday, Inc. (NASDAQ:WDAY)'s shares are down by more than 10% over the past year and by more than 3% year-to-date.

Keep Reading →

September 4 - News

« Older Entries
Hedge Fund Resource Center Hedge Fund Resource Center
  • How to Best Use Insider Monkey to Increase Your Returns
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
  • 6 Things You Didn't Know About Hedge Funds
Hot Topics

Apple (AAPL)

Latest Stock News - Company Profile

Warren Buffett

News & Analysis - Portfolio & Stock Picks

Biggest Insider Purchases & Sales

News & Analysis - Data Screener

Google (GOOG)

Latest Stock News - Company Profile

Microsoft (MSFT)

Latest Stock News - Company Profile

Lists

11 Largest Uranium Producing Countries in the World

11 Largest Uranium Producing Countries in the World

12 Fastest Declining Economies in the World in 2026

12 Fastest Declining Economies in the World in 2026

10 Most Popular Stocks on Robinhood in 2026

10 Most Popular Stocks on Robinhood in 2026

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

15 Innovative Healthcare Stocks to Buy According to Analysts

15 Innovative Healthcare Stocks to Buy According to Analysts

9 High Growth Small Cap Stocks That Are Profitable

9 High Growth Small Cap Stocks That Are Profitable

20 Most Profitable Stocks of the Last 20 Years

20 Most Profitable Stocks of the Last 20 Years

15 High Growth Mid-Cap Stocks to Buy

15 High Growth Mid-Cap Stocks to Buy

Top 10 Oncology Stocks to Buy Now

Top 10 Oncology Stocks to Buy Now

10 Best Investments During A Recession

10 Best Investments During A Recession

7 Best Rare Earth Stocks to Buy According to Hedge Funds

7 Best Rare Earth Stocks to Buy According to Hedge Funds

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

11 Best Cancer Stocks to Buy Right Now

11 Best Cancer Stocks to Buy Right Now

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

20 Countries with the Highest Homeless Population

20 Countries with the Highest Homeless Population

12 Countries with the Highest Bond Yields in the World

12 Countries with the Highest Bond Yields in the World

20 Countries with the Most Battle Tanks in the World

20 Countries with the Most Battle Tanks in the World

12 Best Nasdaq Stocks Under $20 to Buy Now

12 Best Nasdaq Stocks Under $20 to Buy Now

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Worst Performing Currencies of 2024

10 Worst Performing Currencies of 2024

16 Countries with the Largest Proven Oil Reserves in the World

16 Countries with the Largest Proven Oil Reserves in the World

16 Highest Quality Chocolate Brands in the US

16 Highest Quality Chocolate Brands in the US

20 Countries with the Strongest Armies in the World

20 Countries with the Strongest Armies in the World

Top 13 English Speaking Countries in Asia

Top 13 English Speaking Countries in Asia

20 States with Highest Female to Male Ratio in the US

20 States with Highest Female to Male Ratio in the US

20 States with the Lowest Life Expectancy in the US

20 States with the Lowest Life Expectancy in the US

25 Cities with the Highest Homeless Population in the World

25 Cities with the Highest Homeless Population in the World

30 Cities with the Highest Weed Consumption in the US

30 Cities with the Highest Weed Consumption in the US

25 Countries with the Highest Alcohol Consumption per Capita

25 Countries with the Highest Alcohol Consumption per Capita

10 Best Gold Stocks Under $30

10 Best Gold Stocks Under $30

10 Best Genomics Stocks To Buy Right Now

10 Best Genomics Stocks To Buy Right Now

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use Disclosure Policy FAQ CCPA - Do Not Sell My Information. ©2026 Koala Guide LLC.